Human Papillomavirus Prophylaxis Blog
Join the 'Human Papillomavirus Prophylaxis' group to help and get support from people like you.
New Evidence Supports HPV Vaccine
Posted 3+ months ago by Drugs.com
MONDAY, July 6 – The human papillomavirus (HPV) vaccine is highly effective at preventing precancerous cervical lesions that can lead to cervical cancer, a new study shows.
The researchers also found that the HPV-16/18 AS04-adjuvanted vaccine also appears to protect against other cancer-causing HPV types closely related to HPV-16/18, most notably HPV-31 and HPV-45.
The study of women aged 15 to 25, who received three vaccine doses over six months, found that it was as much as 98 percent effective against HPV-16/18, and between 37 percent and 54 percent effective against 12 other cancer-causing HPV types. Read more...
Related support groups: Human Papillomavirus Prophylaxis
Cervical Cancer Vaccine Not Just for Teens
Posted 3+ months ago by Drugs.com
TUESDAY, June 2 – The human papillomavirus (HPV) vaccine works for women aged 24 to 45 who aren't already infected by HPV, the virus that has been linked to cervical cancer and other cervical diseases.
That's the finding from Dr. Nubia Munoz, of the National Institute of Cancer in Bogota, Colombia, who noted that women's rising age at first marriage and increasing divorce rates have led to more widespread premarital intercourse and pairing with new sexual partners around middle age. Read more...
Related support groups: Gardasil, Human Papillomavirus Prophylaxis
Broad-Spectrum Cervical Cancer Vaccine Shows Promise
Posted 3+ months ago by Drugs.com
TUESDAY, May 26 – An investigational broad-spectrum cervical cancer vaccine induced strong immune responses in mice and rabbits, and protected them against human papillomavirus (HPV) type 16 for four months, new research has found.
Current HPV L1-based vaccines provide almost 100 percent protection against the two types of HPV that cause 70 percent of all cervical cancer cases worldwide, but they are expensive and offer only limited protection against other HPV types that cause cancer, according to the researchers. The new vaccine may help cover that gap in protection, they noted.
When the candidate vaccine was used with a substance such as alum to stimulate immune response, the animals were protected against infection by HPV type 16, the study found. Read more...
Related support groups: Human Papillomavirus Prophylaxis
Circumcision Guards Against STDs
Posted 3+ months ago by Drugs.com
WEDNESDAY, March 25 – The decision of whether or not to circumcise an infant can be a difficult one, but new research suggests that having the procedure may reduce the risk of certain infections later in life.
In a study of more than 5,000 uncircumcised adult Ugandan males, researchers found that after circumcision, the rates of infection with the virus that causes herpes went down by 28 percent, and the transmission of human papillomavirus (HPV) – the virus that can cause cervical cancer and genital warts – was reduced by 35 percent.
In a previous study, the same researchers found that circumcision reduced infection with the HIV virus by 60 percent. Two other research groups – one working in Kenya and the other in South Africa – have also had similar findings. Read more...
Related support groups: Human Papillomavirus Prophylaxis
HPV Data May Aid Vaccine's Effectiveness
Posted 3+ months ago by Drugs.com
TUESDAY, March 24 – The majority of invasive cervical cancers in New Mexico in the 1980s and 1990s contained DNA from human papillomavirus type 16 (HPV16) and HPV type 18 (HPV18), says a new study.
It also found that women diagnosed with HPV16- or HPV18-positive cancers were an average of five years younger than those diagnosed with cancers associated with other HPV types.
The HPV vaccine (Gardasil) protects against infections caused by HPV16 and HPV18, so the new findings may have implications for future cancer screening programs, the researchers said. Read more...
Related support groups: Gardasil, Human Papilloma Virus, Human Papillomavirus Prophylaxis, Cervical Cancer
Get to Know the Pap Test
Posted 3+ months ago by Drugs.com
SUNDAY, Feb. 8 – Since it was introduced to American women in the 1950s, the Pap test has been credited with drastically reducing the number of lives lost to cervical cancer.
Pap tests can detects abnormalities in the cervix before cancer develops – a key ability for a disease, such as cervical cancer, that has few visible symptoms.
Experts at the University of Texas M. D. Anderson Cancer Center say that women should be aware of six facts about the Pap test and cervical cancer: Read more...
Related support groups: Gardasil, Human Papilloma Virus, Human Papillomavirus Prophylaxis, Cervical Cancer
Most Young, Black Females Are Not Getting HPV Vaccine
Posted 3+ months ago by Drugs.com
WEDNESDAY, Feb. 4 – The human papillomavirus (HPV) vaccine, which helps cut a sexual active female's risk of cervical cancer, is viewed positively by its target audience in the black community, even though few are actually getting the shots, a new survey says.
Only one in four eligible black adolescents has received the vaccine, according to a survey by the Pennsylvania Department of Public Health, which is behind funding to find ways to increase HPV vaccination rates among high-risk populations. The results of the survey were to be presented at the American Association for Cancer Research conference on the Science of Cancer Health Disparities in Carefree, Ariz. Read more...
Related support groups: Gardasil, Human Papillomavirus Prophylaxis
Cervical Cancer Vaccine Called Safe
Posted 3+ months ago by Drugs.com
WEDNESDAY, Oct. 22 (HealthDay) – Gardasil, the two-year-old vaccine that's designed to prevent cervical cancer, is safe, U.S. officials said Wednesday.
The U.S. Centers for Disease Control and Prevention's Immunization Safety Office said a study of 370,000 doses given to girls and young women over the past two years found no evidence that the vaccine causes an increased risk of blood clots or other serious conditions, Bloomberg News reported.
The CDC, which recommends the vaccine for girls starting at ages 11 and 12, based its findings on statistics from the Vaccine Safety Datalink, which uses medical data to test hypotheses about vaccine safety, the news service said. Read more...
Related support groups: Gardasil, Human Papillomavirus Prophylaxis
Cervical Cancer Vaccine Worth the Cost: Study
Posted 3+ months ago by Drugs.com
WEDNESDAY, Aug. 20 – Vaccinating all 12-year-old girls against the virus that causes cervical cancer, along with "catch-up" immunizations of women under the age of 21 and revised screening guidelines, would be cost-effective ways to combat the disease, a new study by Harvard researchers suggests.
But this conclusion, published in the Aug. 21 issue of the New England Journal of Medicine, is based on computer modeling rather than "real world" data, leading some experts, including the authors of a related editorial, to question the advisability of implementing widespread vaccination programs. Read more...
Related support groups: Human Papillomavirus Prophylaxis
FDA Medwatch Alert: Unapproved Over The Counter Drugs Marketed for Prevention and Treatment of STDs
Posted 3+ months ago by Drugs.com
[Posted 03/06/2008] FDA advised healthcare professionals and consumers that the Agency issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the internet to U.S. consumers for the prevention and treatment of sexually transmitted diseases (STDs). The products are marketed under the names Tetrasil, Genisil, Aviralex, OXi-MED, Imulux, Beta-mannan, Micronutrient, Qina, and SlicPlus. The products claim to prevent or treat a variety of STDs, including Herpes, Chlamydia, Human Papilloma Virus, cervical dysplasia, and HIV/AIDS. The products pose a serious health threat to unsuspecting consumers who don't know that these products are not FDA approved and have not been proven safe or effective. Consumers who are currently using the Read more...
Related support groups: HIV Infection, Chlamydia Infection, Human Papilloma Virus, Human Papillomavirus Prophylaxis, Herpes Simplex -- Prophylaxis, Herpes Simplex -- Suppression, Cervical Dysplasia
